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A Novel Gene Product that Couples TCR
Signaling to Fas(CD95) Expression in
Activation-Induced Cell Death
Chae Gyu Park,²³ Soo Young Lee,²³ antibody or agonistic ligands, the addition of actinomy-
cin D, cycloheximide, or cyclosporin A inhibited anti-Gokul Kandala,* Sang Yull Lee,*
TCR-induced apoptosis of T cell hybridomas (Ucker etand Yongwon Choi*²
al., 1989, 1994; Green et al., 1994). In addition, glucocor-*Howard Hughes Medical Institute
ticoids or irradiation also induces apoptosis in T cell²The Rockefeller University
hybridomas (Ucker et al., 1989, 1994; Green et al., 1994).New York, New York 10021
Because of these similar properties, T cell hybridomas
have been used as an in vitro model for the study of
anti-TCR-induced apoptosis of thymocytes and T cells.
Summary Using T cell hybridomas, several experiments identi-
fied a few genes that appeared to be important in the
Cross-linking the TCR in T cell hybridomas induces regulation of anti-TCR-induced apoptosis. It was shown
cell apoptosis following activation. This activation- that anti-TCR-induced apoptosis of T cell hybridomas
induced apoptosis has been used as a model for clonal is in part mediated by Fas±Fas ligand (FasL) interaction
deletion of thymocytes or peripheral T cells. Anti-TCR- (Brunner et al., 1995; Dhein et al., 1995; Ju et al., 1995;
induced apoptosis of T cell hybridomas requires de Nagata and Golstein, 1995; Yang et al., 1995). It was
novo macromolecular synthesis, including up-regula- shown that inhibition of c-myc expression by antisense
tion of Fas and FasL. The Fas±FasL interactiom then oligonucleotides blocked anti-TCR-induced apoptosis
activates the apoptosis program. To study apoptosis- of T cell hybridomas (Shi et al., 1992; Green et al., 1994).
specific signaling processes, we generated a mutant T nur77, a gene that is induced by anti-TCR antibody treat-
cell hybridoma line defective in induction of apoptosis, ment of T cell hybridomas (Liu et al., 1994; Woronicz et
but competent to induce activation, upon TCR trig- al., 1994; Yazdanbakhsh et al., 1995), is required for
gering. Subsequently, we cloned the gene TDAG51, induction of anti-TCR-induced apoptosis of T cell hy-
which restored activation-induced apoptosis when bridomas (Liu et al., 1994; Woronicz et al., 1994; Calnan
transfected into the mutant cell line, and showed that et al., 1995). In addition, the function of nur77 was
TDAG51 expression was required for Fas expression. blocked by cyclosporin A, a reagent that also inhibits
Thus, TDAG51 plays an essential role in induction of anti-TCR-induced apoptosis (Yazdanbakhsh et al.,
apoptosis by coupling TCR stimulation to Fas ex- 1995). Furthermore, transgenic mice expressing a domi-
pression. nant negative form of nur77 showed some defects in
clonal deletion of self-reactive thymocytes (Calnan et
al., 1995). Although it has been suggested that T cell
Introduction hybridomas can only model peripheral T cell deletion
because Fas±FasL plays a pivotal role in anti-TCR-
The peripheral T cell repertoire is determined by positive induced apoptosis of T cell hybridomas, experiments
and negative selection of immature thymocytes during on nur77 by Calnan et al. (1995) suggest that apoptosis-
development in the thymus (Nossal, 1994; von Boehmer, regulatory genes (e.g., nur77) identified in T cell hybrido-
1994). Most self-reactive immature thymocytes are elim- mas may also turn out to play a role in the deletion of
inated during development by negative selection (clonal immature thymocytes. Therefore, results derived from
deletion) to establish immunological self-tolerance experiments on T cell hybridoma cell death can parallel
(Kappler et al., 1987; Sha et al., 1988; Murphy et al., thymocyte and peripheral T cell death in vivo.
1990; Kawabe and Ochi, 1991). This process of clonal Despite identification of several genes involved in
deletion is thought to be mediated by apoptosis (Mac- anti-TCR-induced apoptosis, the mechanisms of how
Donald and Lees, 1990; Murphy et al., 1990). Apoptosis these gene products interact to regulate the apoptosis
also plays a major role in the clonal deletion of autoreac- of T cells is not well understood, which may require the
tive T cells in the periphery and in the elimination of identification of more apoptosis±regulatory genes. To
activated T cells after mounting a proper immune re- facilitate the identification of anti-TCR-induced death
sponse (Webb et al., 1990; Kawabe and Ochi, 1991; signaling±specific genes, we have adopted a system
Lenardo, 1991; Russell et al., 1991). involving somatic cell genetics. In this study, we gener-
Much of the signaling processes during activation- ated a T cell hybridoma mutant resistant to the anti-
induced apoptosis of T cells has been studied using T TCR-induced apoptosis, but showing normal activation
cell hybridomas (Ashwell et al., 1987; Ucker et al., 1989; processes. By differential cDNA library screening and
Shi et al., 1992). When stimulated with antigens or anti-T transfection experiments, we identified a novel gene,
cell receptor (TCR) antibodies, T cell hybridomas pro- TDAG51, which complemented the defects in themutant
duce interleukin-2 (IL-2) but also undergo apoptosis cell line. TDAG51 encodes a proline±glutamine±histi-
(Ucker et al., 1989, 1994; Green et al., 1994). Similar to dine-rich protein and shows some similarity to transcrip-
the apoptosis of normal T cells induced by anti-TCR tion activators. Subsequent studies showed that func-
tional TDAG51 is required for Fas(CD95) expression,
which plays a critical role in the activation-induced
apoptosis of T cell hybridomas.³The first two authors contributed equally to this work.
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Figure 1. A Death-Resistant T Cell Hybrid-
oma, KCIT1-8.5
(A) The mutant T cell hybridoma, KCIT1-8.5,
shows surface TCR expression similar to the
parental cell line, KMls-8.3.5. Thin solid line,
phycoerythrin (PE)±streptavidin alone; dotted
line marked with an arrow, biotinylated anti-
TCR antibody plus PE±streptavidin.
(B) KCIT1-8.5 is resistant to apoptosis in-
duced either by anti-TCR antibody or by PMA
plus ionomycin, but KCIT1-8.5 is susceptible
to apoptosis induced by dexamethasone. T
cell hybridomas (4 3 104 cells/well) were cul-
tured in media only, in wells coated with anti-
TCR antibody or in media with 1 mM dexa-
methasone (Sigma), or in media with PMA (12
nM, Calbiochem), ionomycin (0.5 mM, Calbio-
chem), or both, as indicated. After 24 hr, cell
viability was measured by trypan blue uptake.
Representative results of at least three inde-
pendent experiments are shown.
(C) Survival of KCIT1-8.5. The normal parental
line (KMls-8.3.5) or the mutant line (KCIT1-
8.5) was cultured in 96-well plates (4 3 104
cells/well) coated with the indicated amounts
of anti-TCR antibody (H57±597) (Kubo et al.,
1989). Cell viability was measured by trypan
blue uptake at the indicated times.
(D) The mutant T cell hybridoma, KCIT1-8.5, is resistant to apoptosis, but has a normal dose±response curve for IL-2 production upon TCR
stimulation. The normal parental line (KMls-8.3.5) or the mutant line (KCIT1-8.5) was cultured in 96-well plates (4 3 104 cells/well) coated with
the indicated amounts of anti-TCR antibody (H57-597) (Kubo et al., 1989). After 24 hr, supernatants were used to measure IL-2 production
as described (Yazdanbakhsh et al., 1995) and the cells were used for the MTT assay to determine cell viability (Shi et al., 1992). Representative
results of at least three independent experiments are shown.
Results and Discussion the parental cell line, KMls-8.3.5 (Figure 1A), was resis-
tant to the apoptosis induced by anti-TCR antibody and
also by phorbol myristate acetate (PMA) and ionomycinIsolation and Characterization of Death-Resistant
T Cell Hybridoma Mutant (Figure 1B). The longer incubation of cells with anti-TCR
antibody did not significantly affect the cell viability ofTo study the signaling processes involved in apoptosis
specifically, we generated mutant T cell hybridomas re- KCIT1-8.5 (Figure 1C). However, both the parental line
(KMls-8.3.5) and KCIT1-8.5 had a similar dose±responsesistant to apoptosis, yet showing normal activation (i.e.,
IL-2 production) upon TCR stimulation. A T cell hybrid- curve for IL-2 production in response to the same anti-
TCR stimulation (Figure 1D). To test whether defect(s)oma, KMls-8.3.5, was mutagenized with the frameshift
mutagen, ICR-191, because it has been successfully is specific to the TCR-mediated apoptosis, KCIT1-8.5
was also treated with a synthetic glucocorticoid, dexa-used to induce recessive mutants in mammalian cells
(Pellegrini et al., 1989). For mutagenesis, 5 3 107 of methasone (Ucker et al., 1989; Zacharchuk et al., 1990).
Different from anti-TCR antibody or PMA and ionomycin,exponentially growing T cell hybridomas, KMls-8.3.5,
were treated with ICR191 such that 90% of the target dexamethasone induced apoptosis in KCIT1-8.5 as effi-
ciently as in the parental T cell hybridoma, KMls-8.3.5cells were killed. After ICR191 treatment, cells were
washed several times with balanced salt solution and (Figure 1B). These results suggest that defect(s) in
KCIT1-8.5 is specific to the death-signaling pathway viaallowed to recover. Mutagenized cells were then cul-
tured on plates coated with anti-TCR antibody and the TCR.
death-resistant clones were selected. Only the clones
that were resistant to anti-TCR-induced apoptosis, yet Isolation of TDAG51, Which Complements
the Defect(s) in KCIT1-8.5showed normal IL-2 production in response to anti-TCR
antibodies, were selected. Many of the clones resistant To identify the gene(s) responsible for the defect of
KCIT1-8.5, we isolated cDNA clones that were differen-to anti-TCR-induced apoptosis also failed to produce
IL-2, and these were not further studied. Out of 5 3 107 tially expressed in KCIT1-8.5 compared with KMls-8.3.5.
A cDNA library from TCR-stimulated KMls-8.3.5 wascells, four independent death-resistant T cell hybridoma
mutants were isolated (data not shown), and one of differentially screened with cDNA probes made from
KMls-8.3.5 or KCIT1-8.5, both of which were stimulatedthem, KCIT1-8.5, was further studied. When 1 3 108
unmutagenized KMls-8.3.5 cells were used for the same with anti-TCR antibody. Since cell activation of KCIT1-
8.5 upon TCR stimulation was unaffected, the differen-selection procedure on anti-TCR antibody-coated
plates, we were not able to isolate any clone that was tial cDNA library screening used was likely to isolate
genes required for anti-TCR-induced apoptosis specifi-resistant to anti-TCR-induced apoptosis, yet positive for
IL-2 production (data not shown). cally. With this protocol, we isolated cDNA clone
TDAG51 (for T cell death±associated gene 51), whoseKCIT1-8.5, which expressed surface TCR similar to
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sense or antisense orientation. As controls, KCIT1-8.5
was also infected with viruses containing only the neo
gene. None of the transfectants expressing antisense
TDAG51 cDNA or vector alone became susceptible to
anti-TCR-induced apoptosis (Figure 3A). However, all
transfectants expressing sense TDAG51 cDNA became
susceptible to anti-TCR-induced apoptosis, although to
a lesser degree than KMls-8.3.5 (Figure 3A). Anti-TCR-
induced apoptosis of both KMls-8.3.5 and the TDAG51-
transfected KCIT1-8.5 was blocked in a dose-depen-
dent manner by soluble Fas±Fc (Ju et al., 1995) (Figure
3B.). These results establish two points. First, TDAG51
must be essential for anti-TCR-induced apoptosis, since
expression of wild-type TDAG51 complemented the de-
fect in KCIT1-8.5. Second, constitutive expression of
TDAG51 alone is not sufficient to induce apoptosis.
Since the number of G418-resistant clones obtained
from all three vectors was similar, it is unlikely that the
transfectants expressing low levels of TDAG51 were
selected. Rather, it suggests that TDAG51 is transducing
the signals from TCR to the apoptotic machinery or
requires additional gene products, which are induced
by TCR stimulation.
DNA sequence analysis of overlapping TDAG51 cDNA
clones obtained from the mouse T cell hybridoma cDNA
library revealed that TDAG51 cDNA is 1955 nt long and
Figure 2. Isolation and Characterization of the TDAG51 cDNA ends in a canonical polyadenylation signal (Figure 4A).
(A) TDAG51 is up-regulated in KMls-8.3.5 upon TCR stimulation, but The longest protein that might be encoded by the
not in the mutant line, KCIT1-8.5. Polyadenylated RNA purified TDAG51 gene would z46 kDa, with a start site at nucleo-
from unstimulated (c) or TCR-stimulated (a) cells was analyzed for
tides 120±122, but another potential start site (nucleo-TDAG51 expression by Northern blot analysis as described(Maniatis
tides 552±555) would encode protein of z30 kDa (Figureet al., 1989). After analysis, the filter was washed and hybridized
4A). Since the original TDAG51 cDNA clone used in thewith a glyceraldehyde phosphate dehydrogenase (GAPDH) probe
to control the amounts of mRNA loaded as described previously transfection experiments described above contained
(Yazdanbakhsh et al., 1995). All northern analyses were quantified the sequence nucleotides 284±1769, it was likely that
using a Phosphoimager (Molecular Dynamics, Incorporated). the start site at nucleotides 552±555 would be used to
(B) TDAG51 expression in tissues. Total RNAs from different tissues
encode TDAG51 protein. To test this, full-length cDNAwere hybridized with a TDAG51 cDNA probe. Equal amount of RNA
and two 59 truncated TDAG51 cDNAs were analyzed bywas loaded in each lane based on the intensity of EtBr-stained
in vitro translation assay and by transient transfectionribosomal RNA (data not shown). Abbreviations: Br, brain; He, heart;
In, intestine; Ki, kidney; Lu, lung; L.N., lymph nodes; Sp, spleen; Th, assay (Figures 4B±4D).
thymus. When it was in vitro translated, full-length TDAG51
(C) TDAG51 mRNA induction following activation. cDNAs were pre- cDNA (51/HA-A) encoded two major proteins migrating
pared from splenocytes stimulated with PMA (20 ng/ml) and iono-
at z65 kDa and z40 kDa, both of which migrated slowermycin (2 mM) for 1, 3, 6, 12, and 24 hr. The cDNAs were then sub-
than the expected sizes (46 kDa or 30 kDa), on SDS±jected to PCR using TDAG51-specific, Fas-specific, oractin-specific
PAGE. Both of the 59 truncated TDAG51 genes thatprimers. Similar results were obtained when splenocytes were stim-
ulated with plastic-bound anti-TCR antibodies (data not shown). would allow initiation of protein synthesis at Met (nucleo-
tides 552±555) produced in vitro translated proteins mi-
grating at z40 kDa, which was at the same position asexpression was greatly reduced in KCIT1-8.5 in compar-
the smaller product from in vitro translated 51/HA-Aison with KMls-8.3.5. TDAG51 encodes a 2.0 kb mRNA
proteins (Figures 4B and 4C).whose expression in the parental line (KMls-8.3.5) was
For transient transfection analysis, full-length TDAG51strongly induced upon TCR stimulation (Figure 2A). Al-
cDNA and two 59 truncated TDAG51 cDNAs were hem-though TDAG51 mRNA was the same size in both cell
agglutinin (HA) epitope-tagged, cloned into the mamma-lines, its level was reduced around 20-fold in KCIT1-8.5
lian expression vector, pHbAPr±neo, and transfected(Figure 2A). Anti-TCR-induced up-regulation of TDAG51
into 293 cells (Figures 4B and 4D). When transfectedexpression was not sensitive to the treatment of cyclo-
cell lysates were analyzed by Western blot analysis withheximide, suggesting that TDAG51 is one of the immedi-
anti-HA epitope antibody (12CA5), all three constructsate±early gene products induced during TCR stimulation
produced proteins migrating at z40 kDa on SDS±PAGE(data not shown). In mice, TDAG51 was expressed in
(Figure 4D). In addition, polyclonal antibodies againstmost tissues but was more abundant in brain, lung, liver,
the C-terminal 12 aa of TDAG51 protein also detectedand thymus (Figure 2B), and was also up-regulated in
proteins migrating at z40 kDa, which are up-regulatedactivated lymphocytes (data not shown).
upon TCR stimulation (Figure 4E). Therefore, theTo determine the role of TDAG51 in anti-TCR-induced
TDAG51 gene is most likely to encode a protein of 262apoptosis, we infected KCIT1-8.5 with recombinant ret-
roviral viruses carrying wild-type TDAG51 cDNA in either aa that would start at nucleotides 552±555.
Immunity
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Figure 3. TDAG51 Is Required for Anti-TCR-
Induced Apoptosis of T Cell Hybridoma
(A) Expression of wild-type TDAG51 comple-
ments the defect in KCIT1-8.5 cells. Transfec-
tants expressing either sense (TDAG51.1,
TDAG51.3, and TDAG51.12) or antisense
(TDAG51a.1, TDAG51a.3, and TDAG51a.6)
TDAG51 cDNAs were tested for their suscep-
tibility to anti-TCR-induced apoptosis as de-
scribed in Figure 1, and cell viability was mea-
sured by trypan blue uptake. Only three
representative clones from each transfection
are shown. Transfectants expressing vector
alone were also included (Neo.1, Neo.2). A
total of six transfectants expressing anti-
sense TDAG51 and twelve transfectants ex-
pressing vector alone were tested and none of them became susceptible to anti-TCR-induced apoptosis. A total of 12 transfectants expressing
sense TDAG51 cDNA were tested and all became susceptible to anti-TCR-induced apoptosis (data not shown). All experiments were performed
at least three times. All the T cell hybridoma cell lines tested expressed similar levels of TCR and produced normal amounts of IL-2 upon
TCR stimulation (data not shown).
(B) Anti-TCR-induced apoptosis of both KMls-8.3.5 and TDAG51-transfected KCIT1-8.5 is inhibited by soluble Fas±Fc. Cells shown in (A) were
stimulated with anti-TCR antibody as described in Figure 1 in the presence of the indicated concentration of either soluble Fas±immunoglobulin
fusion protein (Fas±Fc; provided by Dr. S.-T. Ju, Harvard Medical School; Ju et al., 1995) or control human IgG1 (hu±Ig; Sigma). After 24 hr,
cell viability was measured by trypan blue uptake. All experiments were carried out at least three times.
Sequence analysis of TDAG51 cDNA in the mutant eral genes that have been reported to be essential for
anti-TCR-induced apoptosis of T cell hybridomas (Shiline, KCIT1-8.5, revealed a frameshift mutation resulting
in a premature translational termination (Figure 4A). This et al., 1992; Liu et al., 1994; Woronicz et al., 1994; Brun-
ner et al., 1995; Dhein et al., 1995; Ju et al., 1995; Yangtype of mutation often causes mRNA instability due to
decreased ribosomal association and may therefore ex- et al., 1995; Yazdanbakhsh et al., 1995). Neither mRNA
expression of nur77 (Figure 5A) nor its DNA bindingplain the reduced level of mRNA (Atwater et al., 1990;
Velazquez et al., 1992). activity (data not shown) was affected in KCIT1-8.5. In
KCIT1-8.5, FasL expression was normal, butFas expres-Analysis using BLAST and FASTA sequence compari-
son algorithms revealed that TDAG51 is very homolo- sion was greatly reduced (Figure 5A). These results sug-
gested that lack of Fas expression may be responsiblegous to a human proline±glutamine-rich protein of un-
known function that was identified from a human fetal for the death-resistance phenotype of KCIT1-8.5.To test
this, KCIT1-8.5 was infected with recombinant retrovi-liver cDNA library. This protein is likely to be a human
homolog of TDAG51, because their amino acid se- ruses carrying Fas cDNA (Watanabe-Fukunaga et al.,
1992) and the Fas1 transfectants were selected by G418quence is about 85% identical. Both mouse and human
TDAG51 did not show any significant similarities to other resistance. When the Fas1±KCIT1-8.5 transfectants
were stimulated with anti-TCR antibody, all the clonesproteins reported previously. Two regions of the protein
have highly repeated sequences; one is composed of became as susceptible to anti-TCR-induced apoptosis
as the parental cell line, KMls-8.3.5 (Figures 5B and 5C).proline±glutamine (PQ) repeats and the other of proline±
histidine (PH) repeats (Figure 4A). The PQ repeats of The results show that KCIT1-8.5 expresses functional
FasL and that the defect(s) in KCIT1-8.5 is indeed lo-TDAG51 showed a strong homology to herpes simplex
cated at or upstream of Fas expression.virus UL36, a transcription activator (McNabb and Court-
We thereforeexamined whether TDAG51 restored Fasney, 1992). The PH repeats of TDAG51 showed a strong
expression in TDAG51-transfected KCIT1-8.5. Althoughhomology to the PRD repeat of various homeobox pro-
constitutive expression of TDAG51 did not restore Fasteins (Gehring et al., 1994). PRD repeat in some homeo-
expression, both Fas mRNA and the surface Fas proteinbox proteins was implicated in the transcriptional activa-
were detected upon TCR stimulation only in those cellstion of target genes (Han et al., 1989; Cai et al., 1994).
that also expressed functional TDAG51 (Figures 5D andWhen fused to the Gal4±DNA binding domain, the amino
5E). Fas expression in the TDAG51 transfectants wasacid residues 154±261 of TDAG51 containing the PQ
still significantly less than in KMls-8.3.5 or Fas-and PH repeats weakly activated a promoter containing
transfected KCIT1-8.5 (Figures 5B and 5E), a fact thatGal4-binding sites (data not shown), suggesting
might account for the lower susceptibility of theTDAG51TDAG51 may work as a transcriptional activator. How-
transfectants to anti-TCR-induced apoptosis. These re-ever, TDAG51 does not contain any obvious DNA bind-
sults show that TDAG51 is essential, but not sufficient,ing motif.
for Fas mRNA expression. Another gene product or
posttranslational modification of TDAG51 induced by
Fas(CD95) Expression Is Defective in KCIT1-8.5 TCR stimulation is likely to be required for Fas ex-
and Requires Functional TDAG51 pression.
To determine how TDAG51 plays a role in anti-TCR- Fas±FasL interaction plays a critical role in the clonal
induced apoptosis, we first examined expression in deletion of autoreactive T cells in the peripheral
lymphoid organs and also in the removal of activatedKCIT1-8.5 and the parental cell line (KMls-8.3.5) of sev-
Novel Gene Essential for T Cell Death
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Figure 4. TDAG51 Protein
(A) Wild-type TDAG51 cDNA sequence and its predicted amino acid sequence. The transcription initiation site (nucleotide 1) was determined
by primer extension analysis (data not shown). The cDNA ends in a canonical polyadenylation signal and poly(A) tail. The GenBank accession
number for TDAG51 cDNA is U44088. The mutation in TDAG51 cDNA in KCIT1-8.5 cells is indicated by (ggctc) (nucleotides 750±755; a deletion
of C at nucleotide 752 or 753 and C±T transition at nucleotide 754). This frame-shift mutation results in the premature termination of TDAG51,
as indicated in the lower line. This was determined by sequencing TDAG51 cDNA clones obtained from KCIT1-8.5 by PCR. Six independent
clones were sequenced and all showed the same mutation.
(B) Constructs of HA±epitope-tagged TDAG51 cDNA were used to detect the TDAG51 protein. HA, HA±epitope tag. The C-terminal 4 aa
residues (SNSA) of TDAG51 prior to the HA tag are indicated. The 59 start site (nucleotide position) of each construct is also indicated.
(C) TDAG51 cDNA encodes a protein starting at nucleotides 552±555. Various 59 truncated TDAG51 cDNAs were in vitro translated and
analyzed on SDS±PAGE followed by autoradiography. TDAG51-specific protein products are marked with an arrow. TDAG51 protein migrates
slower than the expected size (z46 kDa or z30 kDa) on SDS±PAGE.
(D) Expression of HA-tagged TDAG51 in 293 cells. Western blot analysis of cell lysates transfected with expression vectors containing the
constructs described in (B) were carried out with anti-HA antibody (12CA5). Either whole cell lysates (left) or lysates immunoprecipitated with
12CA5 (right) were analyzed by Western blot analysis. All the constructs (51/HA-A, 51/HA-B, and 51/HA-C) produced a protein migrating at
same position (z40 K), indicating that nucleotide 552 was used as the translation initiation site. TDAG51-specific protein products are marked
with an arrow.
(E) Detection of TDAG51 protein in T cell hybridomas. Whole cell lysates were prepared from control, unstimulated KMls-8.3.5 cell line (minus),
or from KMls-8.3.5 cell line stimulated with anti-TCR antibody for 5 hr (plus). Rabbit polyclonal antibody generated against amino acid residues
250±261 were used for Western blot analysis. TDAG51 protein is indicated by an arrow.
(Figure 4 continued on next page)
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T cells that have completed their immune responses Fas expression and increased T cell death following viral
(Nagata and Golstein, 1995). Defect(s) in Fas or FasL infection.
lead to a development of severe autoimmune diseases
Experimental Proceduresas in gld or lpr mice (Cohen and Eisenberg, 1992; Nagata
and Golstein, 1995). Fas±FasL expression upon activa-
Mutagenesis and Selection of Death-Resistanttion of peripheral T cells or T cell hybridomas is a prereq-
T Cell Hybridomas
uisite for the ultimate death of these cells (Brunner et The culturing of T cell hybridomas was described previously (Yaz-
al., 1995; Dhein et al., 1995; Ju et al., 1995; Nagata danbakhsh et al., 1995). For mutagenesis, 5 3 107 (5 3 105 cells/
and Golstein, 1995; Yang et al., 1995). In this study, ml) of exponentially growing T cell hybridomas, KMls-8.3.5, were
we showed that TDAG51 is an immediate±early gene treated with 6 mg/ml of ICR191 (Sigma) for 10 hr. These conditionsfor
mutagenesis were chosen based on their ability to kill approximatelyproduct required for the anti-TCR-induced apoptosis
90% of the target cells. After ICR191 treatment, cells were washedand is an intermediate that couples TCR stimulation
several times with balanced salt solution and cultured in fresh me-with Fas(CD95) expression. Since TDAG51 contains a
dium for 2 days. Following recovery, cells were cultured on plates
transcriptional activation domain and can be translo- coated with 5 mg/ml anti-TCR antibody (Kubo et al., 1989). After 5
cated into nucleus (C. G. P and Y. C., unpublished data), days, surviving cells were recovered, expanded, and recloned by
it is likely that TDAG51 is involved in the transcriptional limiting dilution on 96-well plates coated with anti-TCR antibody.
control of Fas(CD95) mRNA expression. However, al- Only the clones that were resistant to anti-TCR-induced apoptosis,
yet showed normal IL-2 production in response to anti-TCR anti-though genetic evidence suggested that TDAG51 regu-
body, were selected. Four independent T cell hybridoma mutantslates Fas(CD95) mRNA expression, the results in this
described in the text were derived from independent plates duringstudy could not determine whether TDAG51 protein acts
the primary selection.
on the Fas(CD95) promoter directly.
The role of TDAG51 protein appears to be limited to
Fas(CD95) expression, at least in T cell hybridomas, Activation and Induction of Apoptosis
because expression of other surface receptors like TNF- in T Cell Hybridomas
T cell hybridomas were activated by incubating them (4 3 104 cells/R1 or OX40 was not significantly affected in the mutant
well) in 96-well plastic tissue culture plates coated with H57-597cell line, KCIT1-8.5 (data not shown). Future study of
(Kubo et al., 1989). Stimulation of T cellhybridoma was also achievedhow TDAG51 regulates Fas expression will lead to the
by treating cells with PMA (12 nM, Calbiochem), ionomycin (0.5 mM,better understanding of the death-specific signaling
Calbiochem), or both, or by the treatment of cells with dexametha-
processes of anti-TCR-induced apoptosis. Fas expres- sone (1 mM) (Sigma). The activation of T cells was measured by
sion is also increased on lymphocytes during certain lymphokine production, and the viability of T hybridoma cells
viral infections (e.g., HIV) (Nagata and Golstein, 1995). were measured by trypan blue uptake or by MTT assay (Shi et al.,
1989).TDAG51 may also have a role in the up-regulation of
Novel Gene Essential for T Cell Death
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Figure 5. TDAG51 Is Required for Fas(CD95) Expression
(A) Unlike the parental cell line, the mutant line, KCIT1-8.5, does not
express Fas upon TCR stimulation. Polyadenylated RNA purified
from unstimulated (c) or TCR-stimulated (a) cells was analyzed with
cDNA probe for nur77, FasL, and Fas by Northern blot analysis as
described (Maniatis et al., 1989).
(B) Fas expression by the representative transfectants. Neo.1,
KCIT1-8.5 transfected with control vector. Fas.3, KCIT1-8.5
transfected with LXSN-Fas. Thin solid line, PE±streptavidin alone;
dotted line, biotinylated Jo2 plus PE±streptavidin.
(C) Expression of Fas corrects the defect of KCIT1-8.5. Control or
Fas1±KCIT1-8.5 transfectants were cultured on anti-TCR antibody-
coated 96-well plates, and cell viability was measured by trypan blue uptake. Neo.1 and Neo.2, KCIT1-8.5 transfected with control vector.
Fas.3 and Fas.10, KCIT1-8.5 transfected with LXSN-Fas. Six transfectants from each transfection were tested and showed similar results.
(D±E) Expression of TDAG51 allows Fas mRNA and surface protein expression upon TCR stimulation. The TDAG51 transfectants described
in Figure 3 were used for Northern blot and FACS analyses. TDAG51.1 and TDAG51.12, transfectants expressing sense TDAG51 cDNA.
TDAG51a.6, transfectants expressing antisense TDAG51 cDNA. In (D), the expression of transfected genes was determined by the presence
of mRNA hybridized with bacterial aminoglycoside phosphotransferase gene probe (neo). Expression of Fas and GAPDH was determined as
described in (A). c, control, unstimulated; a, TCR-stimulated. In (E), surface Fas expression of control, unstimulated, or TCR-stimulated cells
was analyzed with biotinylated anti-Fas antibody (Jo2) using a FACScan; Thin solid line marked with c, control unstimulated cells; dotted line
marked with an a, TCR-stimulated cells; thick solid lines, cells stained with PE±streptavidin alone.
Isolation and Characterization of TDAG51 cDNA were screened and two clones (p51-2 and p43-1) were found to be
differently expressed in KMls-8.3.5 and KCIT1-8.5. p51-2 was usedA cDNAlibrary in lZAP (Strategene) was madeby standard methods
(Maniatis et al., 1989) from mRNA of KMls-8.3.5, which was stimu- to isolate full-length TDAG51 cDNA. For sequence analysis of
TDAG51, several overlapping cDNA clones were sequenced usinglated with anti-TCR antibody for 6 hr. To identify cDNA clones whose
expression is affected in KCIT1-8.5, duplicate filters of the cDNA the Sequenase Kit (United States Biochemical Company, Cleveland,
Ohio). p51-2, the original cDNA cloneof TDAG51, containing nucleo-library were screened with 32P-labeled cDNA probes made from
mRNA from anti-TCR-stimulated KMls-8.3.5 or anti-TCR-stimulated tides 284±1769 of TDAG51 cDNA, was used for the transfection
experiments described in Figure 3.KCIT1-8.5 as described (Maniatis et al., 1989). Around 1 3 105 clones
Immunity
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For in vitro translation experiments, various TDAG51 cDNAs de- tccttcattttcatt-39; actin (sense), 59-atgaagatcctgaccgagcg-39; actin
(antisense), 59-tacttgcgctgaggaggagc-39.scribed in the text were cloned into pBluescript (Strategene), which
were transcribed and translated in vitro using the TNT coupled retic-
ulocytes system (Promega) with 35S-labeled methionine. Flow Cytometric Analysis
Epitope-tagged TDAG51 was constructed by adding nucleotides Cells were stained and analyzed for expression of TCR and Fas
coding for the sequence LTGGGSGFYPYDVPDYA* to the C-terminal on a FACScan flow cytometer (Becton Dickinson, Mountain View,
end of the TDAG51 open reading frame prior to the termination California) as described previously (Park et al., 1995). Biotinylated
codon. HA epitope (Kolodziej and Young, 1991) is underlined and H57-597 was prepared in our laboratory and biotinylated Jo2 was
the asterisk indicates the stop codon. The 59 ends of the HA-tagged purchased from Pharmingen.
TDAG51 constructs are as follows: 51/HA-A (nucleotide 1), 51/HA-B
(nucleotide 284), and 51/HA-C (nucleotide 549). The HA-tagged
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